Regulation of overgrowth and expression of prostatic binding protein in rat chimeric prostate gland.
Enlargement of the chimeric ventral prostate gland (VP) was induced by directly implanting either fetal urogenital sinus mesenchyme (UGM) or intact fetal urogenital sinus (UGS) into the VP of intact adult rats. The macromolecular content in the chimeric prostate increased from 40-100% (UGM implants) to 200-300% (UGS implants) above control levels. The enlargement of the prostate gland was the result of growth from both the donor tissue and the host gland. Growth of the donor fetal UGS within the host prostate gland may account for the difference observed between the growth induced by fetal UGS and fetal UGM implants. Because fetal UGM regressed when implanted and grown under the renal capsules, the observation of growth in the adult rat VP induced by fetal UGM, either by implanting UGM in situ or forming tissue recombinants of UGM and the adult VP, suggests that fetal UGM requires close association with the VP for the induction of growth to occur. The concentration of an epithelial androgen-dependent protein, the prostatic binding protein (PBP), expressed by the enlarged lobe of the rat VP was similar to that of the control lobe of rat VP. The adult host gland, rather than donor implants, appeared to determine the levels of expression of PBP within the chimeric prostate gland. Immunofluorescence data indicated that PBP was distributed evenly throughout most of the prostatic acini. PBP also accumulated in the lumen of the prostatic acini. Positive immunofluorescence, although less intense, was detected in the UGS remnant, suggesting that fetal UGS was induced by the intact adult VP environment to express PBP. We observed a developmental restriction in the ability of donor prostatic tissues to induce enlargement of the host prostate gland. Fetal UGS was the most effective inducer, whereas neonatal prostatic tissue was marginally effective, and adult prostatic tissue or stromal cells derived from adult VP were completely ineffective.
Thompson
T C
TC
Chung
L W
LW
D000727:Androgen-Binding Protein / Q000378:metabolism*; D000818:Animals; D004247:DNA / Q000378:metabolism; D005455:Fluorescent Antibody Technique; D008297:Male; D008648:Mesoderm / Q000637:transplantation; D051379:Mice; D008819:Mice, Nude; D011467:Prostate / Q000254:growth & development / Q000378:metabolism*; D060789:Prostatein; D012313:RNA / Q000378:metabolism; D011863:Radioimmunoassay; D051381:Rats; D060765:Secretoglobins; D014018:Tissue Distribution; D014566:Urogenital System / Q000196:embryology* / Q000637:transplantation; D014598:Uteroglobin; D060788:Mammaglobin B
D000727:Androgen-Binding Protein; D004247:DNA; D060789:Prostatein; D012313:RNA; D060765:Secretoglobins; D014598:Uteroglobin; C511484:Scgb1d2 protein, rat; C511483:Scgb1d4 protein, rat; C556468:Scgb2a1 protein, rat; D060788:Mammaglobin B